U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419932) titled 'Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer' on Feb. 06.
Brief Summary: This multicenter observational study aims to evaluate the safety and efficacy of neoadjuvant therapy in patients with locally advanced thyroid cancer, focusing on imaging, biochemical, and pathological responses, as well as short-term surgical outcomes and long-term prognosis.
Study Start Date: Dec. 23, 2025
Study Type: OBSERVATIONAL
Condition:
Thyroid Cancer
Thyroid Neoplasms
Intervention:
DRUG: Multitarget Tyrosine Kinase Inhibitors
Patients with or without actionable genomic alterations may receive a multikinase inhibitor (e.g....